S 2227 United States Senate · 118th Congress

Preventing the Financing of Illegal Synthetic Drugs Act

This bill mandates a study by the Government Accountability Office (GAO) to examine how transnational criminal organizations finance the trafficking of synthetic drugs like fentanyl and methamphetamine. The study will analyze business models, online drug markets (including social media and payment apps), money laundering methods, and government efforts to disrupt these illicit financial flows. It directly affects Congress, as the GAO must submit a report detailing findings within one year of the bill's enactment. The bill does not create new laws but aims to identify gaps in combating drug trafficking finance through this targeted analysis.
Bill status in committee 1 of 4 stages cleared
Introduction
Jul 2023
Committee Review
Floor Vote
President
Introduced Jul 11, 2023 Last action Jul 11, 2023
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Jul 11, 2023
Committee
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
upper
Jul 11, 2023
Introduced
Introduced in Senate
upper
1 primary · 2 co-sponsors

Sponsors